Literature DB >> 23324020

Taste masking of naproxen sodium granules by fluid-bed coating.

Ulrike Stange1, Christian Führling, Henning Gieseler.   

Abstract

The taste of oral dosage forms is an important argument regarding patient's compliance and acceptability. For this reason, it is often necessary to mask an undesirable and unpleasant taste of an active pharmaceutical ingredient. The purpose of this study was to mask the taste of naproxen sodium by a new fluid-bed coating approach. Different compositions of coating suspensions were used to coat naproxen sodium granules. It was found that products with the addition of a plasticizer were not stable at 40 °C and tended to agglomerate. Subsequently, formulations without plasticizer were used and the ratio between water and Eudragit® E was varied. Increasing the fraction of water in the suspension from 3% to 14% reduced the effective release of naproxen sodium. An optimum ratio between naproxen sodium granules and Eudragit® E was found to be 1:1.576, where less naproxen sodium was released than the threshold bitter value and an appropriate taste masking for more than 5 min was guaranteed. Investigation of the particle size distribution revealed a d(10) of 138.35 ± 21.52 µm, a d(50 )= 256.40 ± 11.27 µm and a d(90 )= 500.85 ± 69.08 µm, which guarantees an acceptable mouthfeel for patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23324020     DOI: 10.3109/10837450.2012.757784

Source DB:  PubMed          Journal:  Pharm Dev Technol        ISSN: 1083-7450            Impact factor:   3.133


  2 in total

Review 1.  Formulation approaches to pediatric oral drug delivery: benefits and limitations of current platforms.

Authors:  Felipe L Lopez; Terry B Ernest; Catherine Tuleu; Mine Orlu Gul
Journal:  Expert Opin Drug Deliv       Date:  2015-07-13       Impact factor: 6.648

2.  Optimization of taste-masking on ibuprofen microspheres with selected structure features.

Authors:  Wei Qin; Yuanzhi He; Zhen Guo; Liu Zhang; Li Wu; Xianzhen Yin; Shailendra Shakya; Abi Maharjan; Yan Tang; Weifeng Zhu; Jiwen Zhang
Journal:  Asian J Pharm Sci       Date:  2018-06-09       Impact factor: 6.598

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.